Jane Street’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $466K | Sell |
412,630
-704,051
| -63% | -$796K | ﹤0.01% | 3791 |
|
|
2025
Q1 | $1.63M | Buy |
1,116,681
+952,158
| +579% | +$1.39M | ﹤0.01% | 2481 |
|
|
2024
Q4 | $350K | Sell |
164,523
-273,198
| -62% | -$582K | ﹤0.01% | 4452 |
|
|
2024
Q3 | $1.23M | Sell |
437,721
-167,416
| -28% | -$469K | ﹤0.01% | 3101 |
|
|
2024
Q2 | $1.41M | Buy |
605,137
+507,464
| +520% | +$1.18M | ﹤0.01% | 3196 |
|
|
2024
Q1 | $437K | Sell |
97,673
-259,256
| -73% | -$1.16M | ﹤0.01% | 4220 |
|
|
2023
Q4 | $1.15M | Buy |
356,929
+330,276
| +1,239% | +$1.06M | ﹤0.01% | 3155 |
|
|
2023
Q3 | $84.5K | Sell |
26,653
-86,250
| -76% | -$273K | ﹤0.01% | 4672 |
|
|
2023
Q2 | $561K | Buy |
112,903
+52,502
| +87% | +$261K | ﹤0.01% | 3652 |
|
|
2023
Q1 | $298K | Buy |
60,401
+50,307
| +498% | +$249K | ﹤0.01% | 4254 |
|
|
2022
Q4 | $63.5K | Sell |
10,094
-154,913
| -94% | -$974K | ﹤0.01% | 4817 |
|
|
2022
Q3 | $1.78M | Buy |
165,007
+80,706
| +96% | +$872K | ﹤0.01% | 2203 |
|
|
2022
Q2 | $961K | Buy |
84,301
+55,936
| +197% | +$638K | ﹤0.01% | 2824 |
|
|
2022
Q1 | $259K | Sell |
28,365
-38,748
| -58% | -$354K | ﹤0.01% | 4440 |
|
|
2021
Q4 | $1M | Buy |
67,113
+51,759
| +337% | +$772K | ﹤0.01% | 2715 |
|
|
2021
Q3 | $395K | Buy |
+15,354
| New | +$395K | ﹤0.01% | 3671 |
|
|
2021
Q2 | – | Sell |
-11,895
| Closed | -$420K | – | 5127 |
|
|
2021
Q1 | $420K | Sell |
11,895
-17,963
| -60% | -$634K | ﹤0.01% | 3533 |
|
|
2020
Q4 | $753K | Sell |
29,858
-119
| -0.4% | -$3K | ﹤0.01% | 2378 |
|
|
2020
Q3 | $1.13M | Buy |
29,977
+8,872
| +42% | +$334K | ﹤0.01% | 1674 |
|
|
2020
Q2 | $904K | Buy |
+21,105
| New | +$904K | ﹤0.01% | 2023 |
|
|
2019
Q4 | – | Sell |
-27,295
| Closed | -$744K | – | 3237 |
|
|
2019
Q3 | $744K | Buy |
+27,295
| New | +$744K | ﹤0.01% | 1789 |
|